Average Co-Inventor Count = 11.35
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (11 from 2,405 patents)
2. Merck Shapr & Dohme Corp. (1 from 1 patent)
3. Seynix, Inc. (1 from 1 patent)
4. Seynexis, Inc. (1 from 1 patent)
13 patents:
1. 10786488 - Substituted quinolizine derivatives useful as HIV integrase inhibitors
2. 10144741 - Nargenicin compounds and uses thereof as antibacterial agents
3. 9944654 - Nargenicin compounds and uses thereof as antibacterial agents
4. 9868733 - Azabenzimidazole tetrahydrofuran derivatives
5. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives
6. 9540364 - Benzimidazole tetrahydrofuran derivatives
7. 9527839 - Benzimidazole tetrahydropyran derivatives
8. 9382243 - Azabenzimidazole tetrahydropyran derivatives
9. 9290517 - Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
10. 8853212 - Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
11. 8796258 - Cyclic azabenzimidazole derivatives useful as anti-diabetic agents
12. 8722727 - Antifungal agents
13. 8188085 - Antifungal agents